IQVIA HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 231.2 USD | -1.63% |
|
-1.24% | -0.09% |
Presenter SpeechGeorge Smith (Attendees)So I am George Smith. I am the IQVIA Cell and Gene The...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Calendar
23/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
231.2
USD
Average target price
271.4
USD
Spread / Average Target
+17.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +24.73% | 12.17B | |
| +28.31% | 12.16B | |
| -6.26% | 11.42B | |
| +2.05% | 10.14B |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- Transcript : IQVIA Holdings Inc. Presents at Medicine Cell & Gene Meeting on the Mesa, Oct-02-2019 07
